Ask AI

Capsule Summaries

Share

Program Content

Activities

  • LIBRETTO-432
    LIBRETTO-432: Phase III Trial of Adjuvant Selpercatinib in Stage IB-IIIA RET Fusion–Positive NSCLC
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 15, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Supporters

This activity is supported by educational grants from Lilly and PharmaMar.

Incyte Corporation

Lilly

PharmaMar

Stemline Therapeutics, Inc.